MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Oncogene

• Publication date

  2013-01-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/onc.2012.58PMID 22370643PMCID PMC7580497
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of Slug transcription factor in human mesenchymal stem cells

  2012cited by this paper
• Critical and Reciprocal Regulation of KLF4 and SLUG in Transforming Growth Factor β-Initiated Prostate Cancer Epithelial-Mesenchymal Transition

  2011cited by this paper
• Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage

  2011cited by this paper
• LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells.

  2011cited by this paper
• Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis.

  2011cited by this paper
• Genome-wide profiling of chromatin signatures reveals epigenetic regulation of MicroRNA genes in colorectal cancer.

  2011cited by this paper
• Prostate epithelial Pten/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition.

  2011cited by this paper
• p53 regulates epithelial-mesenchymal transition (EMT) and stem cell properties through modulating miRNAs

  2010cited by this paper
• Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells.

  2010cited by this paper
• Characterizing the Contribution of Stem/Progenitor Cells to Tumorigenesis in the Pten−/−TP53−/− Prostate Cancer Model

  2010cited by this paper
• p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug

  2009cited by this paper
• Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

  2009cited by this paper
• TGF-β-induced epithelial to mesenchymal transition

  2009cited by this paper
• Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

  2009cited by this paper
• Epithelial-mesenchymal transitions in development and disease.

  2009cited by this paper
• Slug gene expression supports human osteoblast maturation

  2009cited by this paper
• Lentivirus‐mediated bifunctional cell labeling for in vivo melanoma study

  2009cited by this paper
• Targeting TGF-beta in prostate cancer: therapeutic possibilities during tumor progression.

  2009cited by this paper
• Targeting TGF-β in prostate cancer: therapeutic possibilities during tumor progression

  2009cited by this paper
• A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia

  2009cited by this paper
• The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

  2009cited by this paper
• Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer.

  2008cited by this paper
• Down-regulation of Micro-RNA-1 (miR-1) in Lung Cancer

  2008cited by this paper
• Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis.

  2008cited by this paper
• The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

  2008cited by this paper
• A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

  2008cited by this paper
• p53 Plays a Role in Mesenchymal Differentiation Programs, in a Cell Fate Dependent Manner

  2008cited by this paper
• Activation of the RalGEF/Ral Pathway Promotes Prostate Cancer Metastasis to Bone

  2007cited by this paper
• A Switch from E-Cadherin to N-Cadherin Expression Indicates Epithelial to Mesenchymal Transition and Is of Strong and Independent Importance for the Progress of Prostate Cancer

  2007cited by this paper
• N‐cadherin switching occurs in high Gleason grade prostate cancer

  2006cited by this paper
• Sarcomatoid Carcinoma of the Prostate: A Study of 42 Cases

  2006cited by this paper
• Transforming growth factor-beta promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells.

  2006cited by this paper
• The KinI kinesin Kif2a is required for bipolar spindle assembly through a functional relationship with MCAK

  2004cited by this paper
• Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma.

  1999cited by this paper
• Transforming growth factor β1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer

  1998cited by this paper
• Transforming growth factor beta1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer.

  1998cited by this paper

• Global research landscape and emerging trends of non-coding RNAs in prostate cancer: a bibliometric analysis

  2025cites this paper
• miRNA-mediated resistance mechanisms in prostate cancer: implications for targeted therapy and metastatic progression

  2025cites this paper
• Non-coding RNAs as mediators of epithelial - Mesenchymal transition (EMT) in metastatic colorectal cancers.

  2025cites this paper
• Epigenetic regulation of androgen dependent and independent prostate cancer.

  2024cites this paper
• The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations

  2024cites this paper
• Melatonin and Its Role in the Epithelial-to-Mesenchymal Transition (EMT) in Cancer

  2024cites this paper
• Epithelial–Mesenchymal Transition in Acute Leukemias

  2024cites this paper
• The interplay of metabolic and epigenetic players in disease development.

  2024cites this paper
• Non-Coding RNAs in Breast Cancer: Diagnostic and Therapeutic Implications

  2024cites this paper
• The role of epithelial-mesenchymal transition in the pathogenesis of various diseases: A review

  2024cites this paper
• Relationship of Signaling Pathways between RKIP Expression and the Inhibition of EMT-Inducing Transcription Factors SNAIL1/2, TWIST1/2 and ZEB1/2

  2024cites this paper
• Endometriosis-Associated Ovarian Cancer: From Molecular Pathologies to Clinical Relevance

  2024cites this paper
• miRNA Expression Profiles in Ovarian Endometriosis and Two Types of Ovarian Cancer—Endometriosis-Associated Ovarian Cancer and High-Grade Ovarian Cancer

  2023cites this paper
• MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis.

  2023cites this paper
• Differential Expression of miRNAs Contributes to Tumor Aggressiveness and Racial Disparity in African American Men with Prostate Cancer

  2023cites this paper
• Promising applications of nanotechnology in inhibiting chemo-resistance in solid tumors by targeting epithelial-mesenchymal transition (EMT).

  2023cites this paper
• State-of-the-art therapeutic strategies for targeting cancer stem cells in prostate cancer

  2023cites this paper
• Epithelial-Mesenchymal Plasticity: Implications for Ferroptosis Vulnerability and Cancer Therapy.

  2023cites this paper
• Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies

  2023cites this paper
• Multi-omics analysis of the Indian ovarian cancer cohort revealed histotype-specific mutation and gene expression patterns

  2023cites this paper
• Dissecting the effects of androgen deprivation therapy on cadherin switching in advanced prostate cancer: A molecular perspective

  2023cites this paper
• miR‐140 and miR‐200 regulate the migratory heterogeneity of location‐specific Schwann cell population

  2023cites this paper
• Cancer-Specific miRNAs Extracted from Tissue-Exudative Extracellular Vesicles in Ovarian Clear Cell Carcinoma

  2022cites this paper
• The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis

  2022cites this paper
• Non-coding RNAs and epithelial mesenchymal transition in cancer: molecular mechanisms and clinical implications

  2022cites this paper
• The Role of MicroRNA in the Regulation of Tumor Epithelial–Mesenchymal Transition

  2022influential citation
• SNAIL driven by a feed forward loop motif promotes TGFβ induced epithelial to mesenchymal transition

  2022cites this paper
• An aldehyde dehydrogenase 1A3 inhibitor attenuates the metastasis of human colorectal cancer.

  2022cites this paper
• An overview of prostate cancer (PCa) diagnosis: Potential role of miRNAs

  2022cites this paper
• Prognostic and clinicopathological value of Slug protein expression in breast cancer: a systematic review and meta-analysis

  2022cites this paper
• Transcriptional and post-transcriptional control of epithelial-mesenchymal plasticity: why so many regulators?

  2022cites this paper
• Role of MicroRNAs in Neuroendocrine Prostate Cancer

  2022cites this paper
• Epithelial–mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities

  2022cites this paper
• Investigating Helicobacter pylori-related pyloric hypomotility; Functional, histological and molecular alterations.

  2021cites this paper
• Noncoding RNAs in tumor metastasis: molecular and clinical perspectives

  2021cites this paper
• The Identification of Small Molecule Inhibitors That Reduce Invasion and Metastasis of Aggressive Cancers

  2021cites this paper
• Prognostic and Clinicopathological Value of Slug Expression in Breast Cancer: A Meta-analysis

  2021cites this paper
• Role of Metastasis-Related microRNAs in Prostate Cancer Progression and Treatment

  2021influential citation
• Epigenetics of epithelial to mesenchymal transition (EMT) in cancer

  2021cites this paper
• Bile acids increase intestinal marker expression via the FXR/SNAI2/miR-1 axis in the stomach

  2021cites this paper
• Cell Plasticity and Prostate Cancer: The Role of Epithelial–Mesenchymal Transition in Tumor Progression, Invasion, Metastasis and Cancer Therapy Resistance

  2021cites this paper
• Non-Coding RNAs Set a New Phenotypic Frontier in Prostate Cancer Metastasis and Resistance

  2021cites this paper
• Epithelial–Mesenchymal Transition Associated with Head and Neck Squamous Cell Carcinomas: A Review

  2021cites this paper
• Immunosuppressive Traits of the Hybrid Epithelial/Mesenchymal Phenotype

  2021cites this paper
• TBX2 Drives Neuroendocrine Prostate Cancer through Exosome-Mediated Repression of miR-200c-3p

  2021cites this paper
• miRNA-Based Potential Biomarkers and New Molecular Insights in Ulcerative Colitis

  2021cites this paper
• The role of microRNAs in epithelial to mesenchymal transition and cancers; focusing on mir-200 family.

  2021cites this paper
• Understanding the Components of EMT Proteome and Their Regulations to Identify Biomarkers for Cancer Prognosis

  2021cites this paper
• What we can learn from embryos to understand the mesenchymal-to-epithelial transition in tumor progression.

  2021cites this paper
• MiRNAs and radical prostatectomy: Current data, bioinformatic analysis and utility as predictors of tumour relapse

  2021cites this paper
• Functional Hierarchy and Cooperation of EMT Master Transcription Factors in Breast Cancer Metastasis

  2021cites this paper
• JPX and LINC00641 ncRNAs expression in prostate tissue: a case-control study

  2021cites this paper
• Molecular mechanisms of astragaloside‑IV in cancer therapy (Review).

  2021cites this paper
• Epigenetic mechanisms in cancer

  2021cites this paper
• High-Throughput and Automated Acoustic Trapping of Extracellular Vesicles to Identify microRNAs With Diagnostic Potential for Prostate Cancer

  2021cites this paper
• MicroRNAs and Natural Compounds Mediated Regulation of TGF Signaling in Prostate Cancer

  2021cites this paper
• Application of Nano Drug Delivery Systems in Inhibition of Tumors and Cancer Stem Cells

  2021cites this paper
• A computational systems biology approach identifies SLUG as a mediator of partial Epithelial-Mesenchymal Transition (EMT)

  2020cites this paper
• Scratch2, a Snail Superfamily Member, Is Regulated by miR-125b

  2020cites this paper
• lncRNA lnc-TSI Inhibits Metastasis of Clear Cell Renal Cell Carcinoma by Suppressing TGF-β-Induced Epithelial-Mesenchymal Transition

  2020cites this paper
• Anti-tumor effects of Artemisia nilagirica extract on MDA-MB-231 breast cancer cells: deciphering the biochemical and biomechanical properties via TGF-β upregulation

  2020cites this paper
• Programmed Death Ligand-1 (PD-L1) Regulated by NRF-2/MicroRNA-1 Regulatory Axis Enhances Drug Resistance and Promotes Tumorigenic Properties in Sorafenib-Resistant Hepatoma Cells

  2020cites this paper
• Mitochondrial Damage Mediated by miR-1 Overexpression in Cancer Stem Cells

  2020cites this paper
• Knockdown of ubiquitin-specific protease 51 attenuates cisplatin resistance in lung cancer through ubiquitination of zinc-finger E-box binding homeobox 1

  2020cites this paper
• Long non-coding RNA LINC00152/miR-613/CD164 axis regulates cell proliferation, apoptosis, migration and invasion in glioma via PI3K/AKT pathway.

  2020cites this paper
• Downregulation of miR-1 in colorectal cancer promotes radioresistance and aggressive phenotypes

  2020cites this paper
• Analysis of association between MALAT1 haplotype and the severity of normal‐tension glaucoma (NTG)

  2020cites this paper
• Mitochondrial metabolism and cancer metastasis.

  2020cites this paper
• Harnessing urinary extracellular vesicles microRNA by acoustic trapping as potential biomarkers for prostate cancer

  2020cites this paper
• EMT Factors and Metabolic Pathways in Cancer

  2020cites this paper
• SMAD7 and SERPINE1 as novel dynamic network biomarkers detect and regulate the tipping point of TGF-beta induced EMT.

  2020cites this paper
• Interplay among SNAIL Transcription Factor, MicroRNAs, Long Non-Coding RNAs, and Circular RNAs in the Regulation of Tumor Growth and Metastasis

  2020cites this paper
• Long noncoding RNA HOTAIR promotes medulloblastoma growth, migration and invasion by sponging miR-1/miR-206 and targeting YY1.

  2020cites this paper
• Bile acids increase intestinal markers via FXR/SNAI2/miR-1 axis in the stomach

  2020cites this paper
• MicroRNAs as Theranostics Targets in Oral Carcinoma Stem Cells

  2020cites this paper
• Ectopic Expression of miR-532-3p Suppresses Bone Metastasis of Prostate Cancer Cells via Inactivating NF-κB Signaling

  2020cites this paper
• Ectopic expression of 35 kDa and knocking down of 78 kDa SG2NAs induce cytoskeletal reorganization, alter membrane sialylation, and modulate the markers of EMT

  2020cites this paper
• mir-1 inhibits migration of gastric cancer cells

  2020cites this paper
• New Actors Driving the Epithelial–Mesenchymal Transition in Cancer: The Role of Leptin

  2020cites this paper
• MicroRNAs in Cancer: From Diagnosis to Therapeutics

  2020cites this paper
• MicroRNA-200c-3p/ZEB2 loop plays a crucial role in the tumor progression of prostate carcinoma.

  2019cites this paper
• The role of miRNAs as biomarkers in prostate cancer.

  2019cites this paper
• miR-1-3p suppresses the epithelial-mesenchymal transition property in renal cell cancer by downregulating Fibronectin 1

  2019cites this paper
• Acute Spinal Cord Injury: A Systematic Review Investigating miRNA Families Involved

  2019cites this paper
• Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis.

  2019cites this paper
• Epithelial mesenchymal transition and resistance in endocrine-related cancers.

  2019cites this paper
• ΔNp63α and MicroRNA: Leveraging the Epithelial-Mesenchymal Transition

  2019cites this paper
• UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC

  2019cites this paper
• Krüppel like factor 6 splice variant 1 (KLF6-SV1) overexpression recruits macrophages to participate in lung cancer metastasis by up-regulating TWIST1

  2019cites this paper
• TGF-β and microRNA Interplay in Genitourinary Cancers

  2019cites this paper
• Molecular mechanisms of epithelial to mesenchymal transition in tumor metastasis.

  2019cites this paper
• Role of MicroRNAs in Anesthesia-Induced Neurotoxicity in Animal Models and Neuronal Cultures: a Systematic Review

  2019cites this paper
• Identification of upstream miRNAs of SNAI2 and their influence on the metastasis of gastrointestinal stromal tumors

  2019cites this paper
• Mitochondrial Damage Mediated by miR-1 Overexpression in Cancer Stem Cells

  2019cites this paper
• Molecular regulation of Snai2 in development and disease

  2019influential citation
• MiR-1/GOLPH3/Foxo1 Signaling Pathway Regulates Proliferation of Bladder Cancer

  2019cites this paper
• High Expression of MicroRNA-196a is Associated with Progression of Hepatocellular Carcinoma in Younger Patients

  2019cites this paper
• Epigenetic Regulation of Inflammatory Cytokine-Induced Epithelial-To-Mesenchymal Cell Transition and Cancer Stem Cell Generation

  2019cites this paper
• Molecular Mechanisms of Action of Genistein in Cancer: Recent Advances

  2019cites this paper
• Functional Role of Non-Coding RNAs during Epithelial-To-Mesenchymal Transition

  2018cites this paper